Treace Medical Concepts, Inc. Operating Cash Flow
Treace Medical Concepts, Inc. (TMCI) reported Operating Cash Flow of $2.54 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-07
- Treace Medical Concepts, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$4.70M.
- Treace Medical Concepts, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was $7.24M, a 72.46% increase year-over-year.
- Treace Medical Concepts, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$8.03M.
- Treace Medical Concepts, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$9.09M.
- Treace Medical Concepts, Inc. net cash provided by (used in) operating activities for fiscal 2025 was -$15.97M.
- Treace Medical Concepts, Inc. net cash provided by (used in) operating activities for fiscal 2024 was -$37.17M.
- Treace Medical Concepts, Inc. net cash provided by (used in) operating activities for fiscal 2023 was -$34.58M.
- Treace Medical Concepts, Inc. net cash provided by (used in) operating activities for fiscal 2022 was -$30.65M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$4.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $2.54M 10-Q · filed 2026-08-07 | -$5.48M derived: sum of 3 quarters · filed 2026-08-07 | -$14.58M derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $7.24M 10-Q · filed 2026-05-08 | -$786.00K derived: sum of 2 quarters · filed 2026-05-08 | -$9.88M derived: sum of 3 quarters · filed 2026-05-08 | -$12.93M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | -$8.03M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$17.12M derived: sum of 2 quarters · filed 2026-02-27 | -$20.17M derived: sum of 3 quarters · filed 2026-08-07 | -$15.97M 10-K · filed 2026-02-27 |
| 2025-09-30 | -$9.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$12.14M derived: sum of 2 quarters · filed 2026-08-07 | -$7.94M 10-Q · filed 2025-11-06 | -$12.15M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | -$3.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $1.15M 10-Q · filed 2026-08-07 | -$3.06M derived: sum of 3 quarters · filed 2026-08-07 | -$14.90M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $4.20M 10-Q · filed 2026-05-08 | -$9.00K derived: sum of 2 quarters · filed 2026-05-08 | -$11.85M derived: sum of 3 quarters · filed 2026-05-08 | -$25.75M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | -$4.21M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$16.05M derived: sum of 2 quarters · filed 2026-02-27 | -$29.95M derived: sum of 3 quarters · filed 2026-02-27 | -$37.17M 10-K · filed 2026-02-27 |
| 2024-09-30 | -$11.84M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$25.74M derived: sum of 2 quarters · filed 2025-11-06 | -$32.96M 10-Q · filed 2025-11-06 | -$32.43M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | -$13.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$21.12M 10-Q · filed 2025-08-07 | -$20.59M derived: sum of 3 quarters · filed 2026-02-27 | -$30.10M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | -$7.22M 10-Q · filed 2025-05-08 | -$6.69M derived: sum of 2 quarters · filed 2026-02-27 | -$16.20M derived: sum of 3 quarters · filed 2026-02-27 | -$24.54M derived: sum of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | $532.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$8.98M derived: sum of 2 quarters · filed 2026-02-27 | -$17.32M derived: sum of 3 quarters · filed 2026-02-27 | -$34.58M 10-K · filed 2026-02-27 |
| 2023-09-30 | -$9.51M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | -$17.85M derived: sum of 2 quarters · filed 2024-11-05 | -$35.11M 10-Q · filed 2024-11-05 | -$40.47M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | -$8.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | -$25.59M 10-Q · filed 2024-08-06 | -$30.95M derived: sum of 3 quarters · filed 2025-02-27 | -$38.44M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | -$17.26M 10-Q · filed 2024-05-07 | -$22.62M derived: sum of 2 quarters · filed 2025-02-27 | -$30.10M derived: sum of 3 quarters · filed 2025-02-27 | -$40.67M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | -$5.36M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$12.84M derived: sum of 2 quarters · filed 2025-02-27 | -$23.41M derived: sum of 3 quarters · filed 2025-02-27 | -$30.65M 10-K · filed 2025-02-27 |
| 2022-09-30 | -$7.48M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$18.05M derived: sum of 2 quarters · filed 2023-11-09 | -$25.29M 10-Q · filed 2023-11-09 | -$29.04M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | -$10.57M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$17.81M 10-Q · filed 2023-08-09 | -$21.56M derived: sum of 3 quarters · filed 2024-02-27 | -$30.82M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | -$7.24M 10-Q · filed 2023-05-09 | -$10.99M derived: sum of 2 quarters · filed 2024-02-27 | -$20.26M derived: sum of 3 quarters · filed 2024-02-27 | -$23.99M derived: sum of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | -$3.75M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | -$13.02M derived: sum of 2 quarters · filed 2024-02-27 | -$16.75M derived: sum of 3 quarters · filed 2024-02-27 | -$17.19M 10-K · filed 2024-02-27 |
| 2021-09-30 | -$9.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$12.99M derived: sum of 2 quarters · filed 2022-11-09 | -$13.44M 10-Q · filed 2022-11-09 | -$10.99M derived: sum of 4 quarters · filed 2023-03-08 |
| 2021-06-30 | -$3.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | -$4.18M 10-Q · filed 2022-08-10 | -$1.73M derived: sum of 3 quarters · filed 2023-03-08 | -$5.93M derived: sum of 4 quarters · filed 2023-03-08 |
| 2021-03-31 | -$446.00K 10-Q · filed 2022-05-06 | $2.00M derived: sum of 2 quarters · filed 2023-03-08 | -$2.20M derived: sum of 3 quarters · filed 2023-03-08 | -$4.04M derived: sum of 4 quarters · filed 2023-03-08 |
| 2020-12-31 | $2.45M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-08 | -$1.75M derived: sum of 2 quarters · filed 2023-03-08 | -$3.60M derived: sum of 3 quarters · filed 2023-03-08 | -$4.49M 10-K · filed 2023-03-08 |
| 2020-09-30 | -$4.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | -$6.05M derived: sum of 2 quarters · filed 2021-11-04 | -$6.94M 10-Q · filed 2021-11-04 | |
| 2020-06-30 | -$1.84M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | -$2.74M 10-Q · filed 2021-08-05 | ||
| 2020-03-31 | -$895.00K 10-Q · filed 2021-05-25 | |||
| 2019-12-31 | -$7.67M 10-K · filed 2022-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |